- Home
- AVBP vs KRUS Comparison
AVBP vs KRUS Comparison
Compare AVBP & KRUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVBP
- KRUS
- Stock Information
- Founded
- AVBP 2021
- KRUS 2008
- Country
- AVBP United States
- KRUS United States
- Employees
- AVBP N/A
- KRUS N/A
- Industry
- AVBP
- KRUS Restaurants
- Sector
- AVBP
- KRUS Consumer Discretionary
- Exchange
- AVBP NYSE
- KRUS Nasdaq
- Market Cap
- AVBP 879.2M
- KRUS 703.7M
- IPO Year
- AVBP 2024
- KRUS 2019
- Fundamental
- Price
- AVBP $21.75
- KRUS $49.96
- Analyst Decision
- AVBP Strong Buy
- KRUS Buy
- Analyst Count
- AVBP 5
- KRUS 9
- Target Price
- AVBP $39.40
- KRUS $87.78
- AVG Volume (30 Days)
- AVBP 172.1K
- KRUS 288.2K
- Earning Date
- AVBP 03-03-2025
- KRUS 04-03-2025
- Dividend Yield
- AVBP N/A
- KRUS N/A
- EPS Growth
- AVBP N/A
- KRUS N/A
- EPS
- AVBP N/A
- KRUS N/A
- Revenue
- AVBP N/A
- KRUS $250,841,000.00
- Revenue This Year
- AVBP N/A
- KRUS $20.95
- Revenue Next Year
- AVBP N/A
- KRUS $20.06
- P/E Ratio
- AVBP N/A
- KRUS N/A
- Revenue Growth
- AVBP N/A
- KRUS 25.68
- 52 Week Low
- AVBP $14.35
- KRUS $48.66
- 52 Week High
- AVBP $36.37
- KRUS $122.81
- Technical
- Relative Strength Index (RSI)
- AVBP 32.12
- KRUS 25.11
- Support Level
- AVBP $21.34
- KRUS $53.50
- Resistance Level
- AVBP $22.75
- KRUS $59.76
- Average True Range (ATR)
- AVBP 1.40
- KRUS 4.40
- MACD
- AVBP -0.14
- KRUS -0.81
- Stochastic Oscillator
- AVBP 8.41
- KRUS 1.76
About AVBP ARRIVENT BIOPHARMA INC
ArriVent BioPharma Inc is a clinical stage biopharmaceutical company dedicated to the identification, development and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers. It seeks to utilize team's deep drug development experience to maximize the potential of lead development candidate, furmonertinib, and advance a pipeline of novel therapeutics, such as next-generation antibody drug conjugates, through approval and commercialization in patients suffering from cancer, with an initial focus on solid tumors.
About KRUS Kura Sushi USA Inc.
Kura Sushi USA Inc is a technology-enabled restaurant concept serving authentic Japanese cuisine through an engaging revolving sushi service model. The company operates a chain of sushi restaurants across the United States serving freshly prepared Japanese cuisine using high-quality ingredients that are free from artificial seasonings, sweeteners, colorings, and preservatives. It offers several dishes, including Dashi Olive Salmon, Tomago, Sweet Shrimp, Tuna, Garlic Tuna Steak, and Salmon, among others.